Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepatocytes | 114 | 2023 | 1211 | 13.650 |
Why?
|
Liver | 118 | 2022 | 7475 | 5.240 |
Why?
|
Cell Culture Techniques | 45 | 2019 | 1678 | 3.960 |
Why?
|
Tissue Engineering | 39 | 2022 | 1880 | 3.930 |
Why?
|
Burns | 48 | 2021 | 1815 | 3.700 |
Why?
|
Electroporation | 9 | 2018 | 251 | 3.520 |
Why?
|
Microfluidic Analytical Techniques | 23 | 2019 | 828 | 3.230 |
Why?
|
Elastin | 12 | 2022 | 308 | 3.090 |
Why?
|
Rats, Inbred Lew | 68 | 2019 | 1162 | 2.880 |
Why?
|
Rats | 190 | 2022 | 24252 | 2.840 |
Why?
|
Embryonic Stem Cells | 17 | 2011 | 1295 | 2.730 |
Why?
|
Fatty Liver | 14 | 2020 | 727 | 2.660 |
Why?
|
Perfusion | 34 | 2022 | 1360 | 2.540 |
Why?
|
Liver Transplantation | 30 | 2020 | 2119 | 2.480 |
Why?
|
Coculture Techniques | 34 | 2016 | 1341 | 2.400 |
Why?
|
Liver, Artificial | 19 | 2010 | 56 | 2.380 |
Why?
|
Models, Biological | 49 | 2023 | 9584 | 2.210 |
Why?
|
Microfluidics | 16 | 2023 | 662 | 2.150 |
Why?
|
Mesenchymal Stem Cells | 20 | 2019 | 1632 | 2.140 |
Why?
|
Organ Preservation | 15 | 2020 | 331 | 2.070 |
Why?
|
Retroviridae | 15 | 2008 | 914 | 1.880 |
Why?
|
Animals | 360 | 2022 | 168768 | 1.860 |
Why?
|
Cells, Cultured | 108 | 2020 | 19233 | 1.710 |
Why?
|
Extracellular Matrix | 18 | 2021 | 1741 | 1.550 |
Why?
|
Alginates | 6 | 2015 | 252 | 1.540 |
Why?
|
Collagen | 29 | 2020 | 2688 | 1.470 |
Why?
|
Rats, Sprague-Dawley | 59 | 2021 | 8300 | 1.460 |
Why?
|
Wound Healing | 22 | 2022 | 2785 | 1.390 |
Why?
|
Liver Regeneration | 4 | 2016 | 210 | 1.380 |
Why?
|
Cell Communication | 11 | 2016 | 1621 | 1.360 |
Why?
|
Disinfection | 4 | 2020 | 191 | 1.350 |
Why?
|
Rejuvenation | 3 | 2023 | 91 | 1.320 |
Why?
|
Liver Failure | 9 | 2012 | 241 | 1.300 |
Why?
|
Cryopreservation | 20 | 2022 | 670 | 1.260 |
Why?
|
Cell Differentiation | 29 | 2020 | 11486 | 1.250 |
Why?
|
Biomedical Engineering | 7 | 2014 | 296 | 1.250 |
Why?
|
Cell Survival | 40 | 2019 | 5882 | 1.220 |
Why?
|
Biopolymers | 2 | 2020 | 189 | 1.200 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2022 | 1115 | 1.180 |
Why?
|
Liver Failure, Acute | 6 | 2012 | 165 | 1.180 |
Why?
|
Electric Stimulation Therapy | 3 | 2020 | 605 | 1.170 |
Why?
|
Energy Metabolism | 15 | 2017 | 2897 | 1.170 |
Why?
|
Fibroblast Growth Factor 7 | 4 | 2020 | 61 | 1.160 |
Why?
|
Tissue Scaffolds | 9 | 2021 | 956 | 1.140 |
Why?
|
Wound Infection | 4 | 2020 | 242 | 1.140 |
Why?
|
Gap Junctions | 4 | 2020 | 233 | 1.120 |
Why?
|
Cicatrix, Hypertrophic | 5 | 2016 | 79 | 1.040 |
Why?
|
Oxygen | 25 | 2019 | 4189 | 1.030 |
Why?
|
Urea | 22 | 2019 | 450 | 1.030 |
Why?
|
Photolysis | 11 | 1998 | 92 | 0.980 |
Why?
|
Liver Diseases | 9 | 2019 | 1253 | 0.930 |
Why?
|
Biotechnology | 10 | 2008 | 281 | 0.930 |
Why?
|
Reperfusion Injury | 6 | 2014 | 1026 | 0.920 |
Why?
|
Nanotechnology | 6 | 2021 | 710 | 0.890 |
Why?
|
Oligopeptides | 3 | 2018 | 1189 | 0.890 |
Why?
|
Amino Acids | 15 | 2013 | 1737 | 0.880 |
Why?
|
Temperature | 14 | 2021 | 2204 | 0.880 |
Why?
|
Mice | 121 | 2022 | 81201 | 0.870 |
Why?
|
Pharmaceutical Preparations | 7 | 2022 | 1070 | 0.870 |
Why?
|
Cytochrome P-450 Enzyme System | 8 | 2022 | 419 | 0.870 |
Why?
|
Dimethylpolysiloxanes | 5 | 2023 | 149 | 0.860 |
Why?
|
Bioreactors | 14 | 2011 | 236 | 0.860 |
Why?
|
Heat-Shock Response | 4 | 2009 | 165 | 0.850 |
Why?
|
Cell Line | 41 | 2020 | 16000 | 0.850 |
Why?
|
Albumins | 22 | 2017 | 568 | 0.840 |
Why?
|
Tissue Preservation | 3 | 2021 | 182 | 0.830 |
Why?
|
Cell Proliferation | 17 | 2020 | 10483 | 0.820 |
Why?
|
Blood Physiological Phenomena | 1 | 2021 | 55 | 0.810 |
Why?
|
Lab-On-A-Chip Devices | 8 | 2023 | 428 | 0.810 |
Why?
|
Transfection | 10 | 2017 | 5895 | 0.800 |
Why?
|
Warm Ischemia | 8 | 2019 | 53 | 0.800 |
Why?
|
Endothelial Cells | 10 | 2023 | 3486 | 0.800 |
Why?
|
Erythropoietin | 3 | 2016 | 726 | 0.780 |
Why?
|
Culture Media | 14 | 2008 | 909 | 0.780 |
Why?
|
Bone Marrow Cells | 8 | 2014 | 2513 | 0.770 |
Why?
|
Immunotoxins | 7 | 1997 | 179 | 0.770 |
Why?
|
Mesenchymal Stem Cell Transplantation | 6 | 2015 | 496 | 0.760 |
Why?
|
Fibroblasts | 16 | 2016 | 4162 | 0.750 |
Why?
|
Regeneration | 7 | 2017 | 1485 | 0.740 |
Why?
|
Cell Separation | 10 | 2016 | 1751 | 0.740 |
Why?
|
Pseudomonas Infections | 5 | 2020 | 613 | 0.730 |
Why?
|
3T3 Cells | 24 | 2010 | 1101 | 0.720 |
Why?
|
Disease Models, Animal | 32 | 2021 | 18034 | 0.720 |
Why?
|
Skin | 15 | 2021 | 4372 | 0.710 |
Why?
|
Gene Expression Profiling | 18 | 2014 | 9445 | 0.710 |
Why?
|
Glucose | 18 | 2020 | 4398 | 0.710 |
Why?
|
Antibodies, Monoclonal | 33 | 2021 | 9274 | 0.700 |
Why?
|
Pseudomonas aeruginosa | 8 | 2020 | 1219 | 0.700 |
Why?
|
Liver Circulation | 5 | 2011 | 164 | 0.690 |
Why?
|
Organ Culture Techniques | 4 | 2015 | 813 | 0.690 |
Why?
|
Stromal Cells | 7 | 2014 | 1355 | 0.690 |
Why?
|
Inflammation | 19 | 2023 | 10637 | 0.690 |
Why?
|
S-Nitroso-N-Acetylpenicillamine | 2 | 2009 | 23 | 0.690 |
Why?
|
T-Lymphocytes | 10 | 2023 | 10183 | 0.680 |
Why?
|
Nanoparticles | 4 | 2022 | 1905 | 0.680 |
Why?
|
Peptides | 10 | 2021 | 4410 | 0.680 |
Why?
|
Paracrine Communication | 4 | 2011 | 278 | 0.680 |
Why?
|
Green Fluorescent Proteins | 9 | 2014 | 2088 | 0.670 |
Why?
|
Drug Evaluation, Preclinical | 8 | 2020 | 1375 | 0.670 |
Why?
|
Plasma | 5 | 2004 | 575 | 0.670 |
Why?
|
Blood | 1 | 2021 | 598 | 0.670 |
Why?
|
Immunomodulation | 2 | 2015 | 541 | 0.670 |
Why?
|
Culture Media, Conditioned | 8 | 2014 | 537 | 0.660 |
Why?
|
Tumor Necrosis Factor-alpha | 13 | 2015 | 4424 | 0.660 |
Why?
|
Keratinocytes | 8 | 2018 | 799 | 0.650 |
Why?
|
Microspheres | 6 | 2016 | 777 | 0.640 |
Why?
|
Reperfusion | 2 | 2010 | 284 | 0.630 |
Why?
|
Cryoprotective Agents | 6 | 2022 | 112 | 0.630 |
Why?
|
Interleukin-1 | 6 | 2005 | 1263 | 0.620 |
Why?
|
Specimen Handling | 2 | 2021 | 694 | 0.620 |
Why?
|
Spinal Cord Injuries | 5 | 2022 | 931 | 0.610 |
Why?
|
Dinoprostone | 3 | 2015 | 601 | 0.610 |
Why?
|
Capsules | 2 | 2017 | 196 | 0.610 |
Why?
|
Cold Temperature | 9 | 2020 | 772 | 0.610 |
Why?
|
Antigen-Antibody Complex | 10 | 1999 | 517 | 0.600 |
Why?
|
Flavanones | 4 | 2011 | 71 | 0.600 |
Why?
|
Skin Aging | 1 | 2018 | 127 | 0.600 |
Why?
|
Taste Perception | 1 | 2017 | 30 | 0.600 |
Why?
|
Tissue Donors | 8 | 2020 | 2241 | 0.600 |
Why?
|
Stem Cells | 7 | 2014 | 3567 | 0.590 |
Why?
|
Gold | 2 | 2012 | 484 | 0.590 |
Why?
|
Metabolic Clearance Rate | 7 | 2009 | 380 | 0.580 |
Why?
|
Oxygen Consumption | 8 | 2010 | 1868 | 0.580 |
Why?
|
Porphyrins | 7 | 1996 | 348 | 0.570 |
Why?
|
Toxicity Tests | 2 | 2020 | 121 | 0.570 |
Why?
|
Microelectrodes | 2 | 2008 | 303 | 0.570 |
Why?
|
Insulin | 20 | 2019 | 6582 | 0.570 |
Why?
|
Metabolism | 4 | 2007 | 196 | 0.560 |
Why?
|
Biosensing Techniques | 4 | 2017 | 668 | 0.540 |
Why?
|
Serum Albumin | 11 | 2014 | 675 | 0.540 |
Why?
|
Polylysine | 3 | 2006 | 133 | 0.530 |
Why?
|
Cell Lineage | 7 | 2011 | 2504 | 0.530 |
Why?
|
Serum Albumin, Bovine | 11 | 1999 | 324 | 0.520 |
Why?
|
Culture Media, Serum-Free | 5 | 2010 | 158 | 0.520 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2017 | 282 | 0.520 |
Why?
|
Longevity | 1 | 2023 | 1071 | 0.520 |
Why?
|
Kinetics | 31 | 2009 | 6476 | 0.520 |
Why?
|
Equipment Design | 18 | 2020 | 3582 | 0.520 |
Why?
|
Appetite | 1 | 2017 | 243 | 0.520 |
Why?
|
Gastric Bypass | 4 | 2017 | 812 | 0.510 |
Why?
|
DNA | 11 | 2015 | 7294 | 0.510 |
Why?
|
Mitochondria, Liver | 3 | 2008 | 187 | 0.510 |
Why?
|
Nitrogen | 4 | 2016 | 344 | 0.510 |
Why?
|
Lipopolysaccharides | 6 | 2020 | 2216 | 0.510 |
Why?
|
Recombinant Fusion Proteins | 5 | 2017 | 3773 | 0.510 |
Why?
|
Ischemia | 5 | 2019 | 1907 | 0.510 |
Why?
|
Interleukin-6 | 11 | 2017 | 3203 | 0.510 |
Why?
|
Skin Irritancy Tests | 1 | 2014 | 4 | 0.510 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2014 | 22 | 0.500 |
Why?
|
Electrodes | 3 | 2017 | 619 | 0.500 |
Why?
|
Adenosine Triphosphate | 9 | 2020 | 2027 | 0.500 |
Why?
|
Transduction, Genetic | 6 | 2006 | 913 | 0.490 |
Why?
|
Glycolysis | 4 | 2013 | 829 | 0.490 |
Why?
|
Receptors, Erythropoietin | 1 | 2014 | 147 | 0.490 |
Why?
|
Hepacivirus | 4 | 2016 | 1379 | 0.490 |
Why?
|
Acinetobacter Infections | 1 | 2015 | 69 | 0.490 |
Why?
|
Humans | 193 | 2023 | 744366 | 0.490 |
Why?
|
Immunophenotyping | 3 | 2014 | 1880 | 0.480 |
Why?
|
Social Isolation | 4 | 2012 | 365 | 0.480 |
Why?
|
Biocompatible Materials | 8 | 2013 | 1736 | 0.480 |
Why?
|
Sepsis | 4 | 2020 | 2593 | 0.480 |
Why?
|
Acute-Phase Proteins | 5 | 2009 | 262 | 0.480 |
Why?
|
Hematoxylin | 1 | 2013 | 64 | 0.480 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2013 | 72 | 0.480 |
Why?
|
Hippocampus | 6 | 2015 | 3675 | 0.480 |
Why?
|
Electrolytes | 4 | 2007 | 282 | 0.470 |
Why?
|
Graft Survival | 8 | 2019 | 3737 | 0.470 |
Why?
|
Macrophages | 8 | 2023 | 5660 | 0.470 |
Why?
|
Acinetobacter baumannii | 1 | 2015 | 107 | 0.460 |
Why?
|
Cell Membrane | 11 | 2016 | 3749 | 0.460 |
Why?
|
Gene Regulatory Networks | 3 | 2011 | 1707 | 0.460 |
Why?
|
Epidermis | 3 | 2015 | 528 | 0.460 |
Why?
|
Adipocytes | 2 | 2011 | 1185 | 0.460 |
Why?
|
Galactosamine | 5 | 2006 | 30 | 0.460 |
Why?
|
Cosmetic Techniques | 1 | 2015 | 135 | 0.450 |
Why?
|
Microvessels | 3 | 2016 | 544 | 0.450 |
Why?
|
Stem Cell Transplantation | 4 | 2014 | 1620 | 0.440 |
Why?
|
Catheterization, Peripheral | 1 | 2016 | 345 | 0.440 |
Why?
|
Proteome | 4 | 2010 | 1798 | 0.440 |
Why?
|
Stomach | 2 | 2017 | 697 | 0.440 |
Why?
|
Protein Engineering | 3 | 2021 | 538 | 0.430 |
Why?
|
Glycoproteins | 5 | 2015 | 2266 | 0.430 |
Why?
|
Signal Transduction | 16 | 2020 | 23404 | 0.430 |
Why?
|
Drug Design | 2 | 2016 | 1076 | 0.430 |
Why?
|
Neurons | 6 | 2018 | 9340 | 0.430 |
Why?
|
Glucagon | 5 | 2016 | 533 | 0.430 |
Why?
|
Triglycerides | 8 | 2017 | 2453 | 0.430 |
Why?
|
Hot Temperature | 9 | 2016 | 1356 | 0.420 |
Why?
|
Brain Injuries | 3 | 2015 | 2029 | 0.420 |
Why?
|
Stress, Physiological | 4 | 2014 | 1403 | 0.420 |
Why?
|
Freezing | 9 | 2022 | 303 | 0.410 |
Why?
|
Interleukin-1beta | 3 | 2015 | 972 | 0.410 |
Why?
|
Acetaminophen | 2 | 2016 | 545 | 0.410 |
Why?
|
Micro-Electrical-Mechanical Systems | 1 | 2011 | 31 | 0.410 |
Why?
|
Extracorporeal Circulation | 3 | 2009 | 182 | 0.400 |
Why?
|
Photochemotherapy | 7 | 1998 | 807 | 0.400 |
Why?
|
Blood Proteins | 3 | 2005 | 1124 | 0.400 |
Why?
|
Immunoassay | 1 | 2015 | 752 | 0.400 |
Why?
|
Mitochondrial Proteins | 2 | 2011 | 994 | 0.400 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 721 | 0.390 |
Why?
|
Computational Biology | 4 | 2011 | 3519 | 0.390 |
Why?
|
Proline | 2 | 2009 | 458 | 0.390 |
Why?
|
Computer Simulation | 18 | 2016 | 6194 | 0.390 |
Why?
|
Connexins | 2 | 2012 | 357 | 0.390 |
Why?
|
Nanocapsules | 1 | 2012 | 91 | 0.390 |
Why?
|
NF-kappa B | 7 | 2016 | 2499 | 0.380 |
Why?
|
Immunoglobulin Allotypes | 11 | 1985 | 56 | 0.380 |
Why?
|
Proteoglycans | 6 | 2015 | 837 | 0.380 |
Why?
|
Aging | 4 | 2023 | 8664 | 0.380 |
Why?
|
Endoderm | 2 | 2010 | 154 | 0.380 |
Why?
|
Cell Aggregation | 3 | 2007 | 244 | 0.380 |
Why?
|
Organ Preservation Solutions | 5 | 2019 | 98 | 0.380 |
Why?
|
Protective Agents | 1 | 2012 | 156 | 0.380 |
Why?
|
Membrane Potentials | 3 | 2009 | 1137 | 0.380 |
Why?
|
Blood Vessels | 1 | 2016 | 1125 | 0.370 |
Why?
|
Boron Compounds | 1 | 2012 | 178 | 0.370 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 7 | 2009 | 504 | 0.370 |
Why?
|
Acute-Phase Reaction | 4 | 2005 | 91 | 0.370 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2011 | 186 | 0.370 |
Why?
|
Regenerative Medicine | 2 | 2011 | 307 | 0.370 |
Why?
|
Microtechnology | 5 | 2017 | 70 | 0.370 |
Why?
|
Proteins | 12 | 2023 | 6100 | 0.370 |
Why?
|
Germ Layers | 2 | 2007 | 73 | 0.370 |
Why?
|
Polymers | 8 | 2016 | 1621 | 0.360 |
Why?
|
Thermodynamics | 10 | 2014 | 594 | 0.360 |
Why?
|
Hexuronic Acids | 4 | 2015 | 144 | 0.360 |
Why?
|
Glucuronic Acid | 4 | 2015 | 148 | 0.360 |
Why?
|
Alanine Transaminase | 6 | 2011 | 592 | 0.360 |
Why?
|
Basement Membrane | 3 | 2010 | 357 | 0.350 |
Why?
|
Rats, Zucker | 4 | 2014 | 128 | 0.350 |
Why?
|
Cell Adhesion | 11 | 2011 | 3144 | 0.350 |
Why?
|
Interferon Regulatory Factor-3 | 3 | 2020 | 123 | 0.350 |
Why?
|
Interleukin-10 | 3 | 2014 | 1200 | 0.350 |
Why?
|
Transplantation | 1 | 2011 | 217 | 0.350 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2015 | 612 | 0.350 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 264 | 0.340 |
Why?
|
Up-Regulation | 6 | 2020 | 4222 | 0.340 |
Why?
|
Microsomes, Liver | 1 | 2009 | 173 | 0.340 |
Why?
|
Lentivirus | 1 | 2012 | 503 | 0.340 |
Why?
|
Time Factors | 42 | 2018 | 40075 | 0.330 |
Why?
|
Culture Techniques | 7 | 1998 | 554 | 0.330 |
Why?
|
Moloney murine leukemia virus | 1 | 2008 | 139 | 0.320 |
Why?
|
Guided Tissue Regeneration | 1 | 2009 | 85 | 0.320 |
Why?
|
Immunosorbents | 3 | 1992 | 22 | 0.320 |
Why?
|
Multiprotein Complexes | 2 | 2014 | 1120 | 0.320 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 5 | 2009 | 280 | 0.320 |
Why?
|
Genetic Vectors | 5 | 2012 | 3424 | 0.320 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 2 | 2006 | 297 | 0.320 |
Why?
|
Solutions | 4 | 2018 | 426 | 0.320 |
Why?
|
Ultrasonography, Interventional | 1 | 2016 | 1486 | 0.320 |
Why?
|
Muscle Proteins | 4 | 2021 | 1158 | 0.320 |
Why?
|
Cell Transplantation | 1 | 2010 | 477 | 0.310 |
Why?
|
Ectoderm | 1 | 2008 | 137 | 0.310 |
Why?
|
Hemagglutinins | 1 | 2008 | 117 | 0.310 |
Why?
|
Cytokines | 9 | 2020 | 7323 | 0.310 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2008 | 248 | 0.310 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1178 | 0.310 |
Why?
|
Pigment Epithelium of Eye | 1 | 2008 | 220 | 0.310 |
Why?
|
Ice | 6 | 2022 | 104 | 0.310 |
Why?
|
Chondroitin Sulfate Proteoglycans | 2 | 1999 | 136 | 0.310 |
Why?
|
Heat-Shock Proteins | 2 | 2009 | 822 | 0.300 |
Why?
|
Male | 97 | 2020 | 350115 | 0.300 |
Why?
|
Genes, Immediate-Early | 1 | 2007 | 101 | 0.300 |
Why?
|
Pentose Phosphate Pathway | 5 | 2013 | 124 | 0.300 |
Why?
|
Ion-Selective Electrodes | 1 | 2006 | 6 | 0.300 |
Why?
|
Female | 89 | 2020 | 380193 | 0.300 |
Why?
|
Spheroids, Cellular | 3 | 2020 | 351 | 0.300 |
Why?
|
Connexin 43 | 1 | 2008 | 207 | 0.290 |
Why?
|
Glycogen | 2 | 2010 | 259 | 0.290 |
Why?
|
Aspartate Aminotransferases | 4 | 2010 | 418 | 0.290 |
Why?
|
Pressure Ulcer | 2 | 2019 | 155 | 0.290 |
Why?
|
Gene Expression Regulation | 14 | 2020 | 12073 | 0.290 |
Why?
|
Mice, Inbred C57BL | 14 | 2017 | 21833 | 0.290 |
Why?
|
Cluster Analysis | 6 | 2014 | 2715 | 0.290 |
Why?
|
Electrophysiology | 1 | 2010 | 1308 | 0.290 |
Why?
|
Ligands | 3 | 2011 | 3282 | 0.290 |
Why?
|
Drug Discovery | 3 | 2011 | 1058 | 0.290 |
Why?
|
Hemoperfusion | 1 | 2006 | 14 | 0.290 |
Why?
|
Sialoglycoproteins | 2 | 2006 | 318 | 0.280 |
Why?
|
Muscle, Skeletal | 6 | 2021 | 4925 | 0.280 |
Why?
|
Optics and Photonics | 1 | 2008 | 321 | 0.280 |
Why?
|
Apolipoproteins B | 1 | 2008 | 374 | 0.280 |
Why?
|
Activins | 1 | 2007 | 208 | 0.280 |
Why?
|
Dextrans | 8 | 1996 | 595 | 0.280 |
Why?
|
Gene Expression | 11 | 2014 | 7798 | 0.280 |
Why?
|
Hydrogen Peroxide | 3 | 2023 | 730 | 0.280 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2008 | 2556 | 0.270 |
Why?
|
Homeostasis | 1 | 2017 | 3339 | 0.270 |
Why?
|
Blotting, Western | 7 | 2015 | 5181 | 0.270 |
Why?
|
Transcription, Genetic | 10 | 2011 | 7721 | 0.270 |
Why?
|
NIH 3T3 Cells | 4 | 2010 | 677 | 0.270 |
Why?
|
Butyrates | 1 | 2006 | 163 | 0.270 |
Why?
|
Surface Properties | 7 | 2023 | 1184 | 0.270 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2010 | 2988 | 0.270 |
Why?
|
Gluconeogenesis | 5 | 2010 | 183 | 0.270 |
Why?
|
Spleen | 4 | 2010 | 2362 | 0.270 |
Why?
|
Escherichia coli Infections | 5 | 2000 | 532 | 0.260 |
Why?
|
Macromolecular Substances | 5 | 2004 | 1454 | 0.260 |
Why?
|
Metal Nanoparticles | 1 | 2010 | 405 | 0.260 |
Why?
|
Protein Biosynthesis | 5 | 2014 | 2126 | 0.260 |
Why?
|
Liver Function Tests | 5 | 2020 | 528 | 0.260 |
Why?
|
Cell Death | 5 | 2014 | 1707 | 0.260 |
Why?
|
Muscular Atrophy | 2 | 2006 | 347 | 0.260 |
Why?
|
Action Potentials | 2 | 2010 | 1806 | 0.260 |
Why?
|
Wounds and Injuries | 2 | 2010 | 2400 | 0.260 |
Why?
|
Genetic Engineering | 2 | 2003 | 951 | 0.260 |
Why?
|
Chondroitin ABC Lyase | 2 | 2022 | 17 | 0.250 |
Why?
|
Immunoconjugates | 2 | 2007 | 901 | 0.250 |
Why?
|
Electromagnetic Fields | 2 | 2019 | 298 | 0.250 |
Why?
|
Magnetics | 3 | 2021 | 606 | 0.250 |
Why?
|
Retinal Detachment | 1 | 2009 | 411 | 0.250 |
Why?
|
Transplantation Conditioning | 2 | 2014 | 1599 | 0.250 |
Why?
|
Citric Acid Cycle | 3 | 2003 | 232 | 0.240 |
Why?
|
Metabolome | 1 | 2011 | 895 | 0.240 |
Why?
|
Ketone Bodies | 4 | 2014 | 82 | 0.240 |
Why?
|
Dehydroepiandrosterone | 1 | 2005 | 252 | 0.240 |
Why?
|
Embryo, Mammalian | 3 | 2006 | 1701 | 0.240 |
Why?
|
Electricity | 2 | 2015 | 182 | 0.240 |
Why?
|
Astrocytes | 1 | 2012 | 1273 | 0.240 |
Why?
|
Receptors, Virus | 3 | 2006 | 649 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 7 | 2017 | 8949 | 0.240 |
Why?
|
Vitrification | 2 | 2021 | 56 | 0.240 |
Why?
|
Apoptosis | 7 | 2020 | 9724 | 0.240 |
Why?
|
Virus Replication | 5 | 2007 | 2535 | 0.240 |
Why?
|
Swine, Miniature | 1 | 2006 | 961 | 0.240 |
Why?
|
Microscopy, Electron, Scanning | 4 | 2015 | 963 | 0.230 |
Why?
|
Mitogens | 1 | 2004 | 232 | 0.230 |
Why?
|
Cells | 2 | 2008 | 168 | 0.230 |
Why?
|
Protein Conformation | 7 | 2021 | 4010 | 0.230 |
Why?
|
Digoxigenin | 2 | 2000 | 26 | 0.230 |
Why?
|
Escherichia coli | 6 | 2016 | 4217 | 0.230 |
Why?
|
Microchip Analytical Procedures | 1 | 2023 | 29 | 0.230 |
Why?
|
RNA, Viral | 2 | 2011 | 2901 | 0.230 |
Why?
|
Photosensitizing Agents | 4 | 1998 | 602 | 0.230 |
Why?
|
beta-Galactosidase | 4 | 1999 | 574 | 0.230 |
Why?
|
Pancreas | 1 | 2010 | 1687 | 0.230 |
Why?
|
Receptors, LDL | 1 | 2006 | 476 | 0.230 |
Why?
|
Cell Physiological Phenomena | 2 | 2007 | 154 | 0.230 |
Why?
|
Cell Movement | 5 | 2013 | 5218 | 0.230 |
Why?
|
Cytochrome P-450 CYP1A1 | 4 | 2014 | 91 | 0.220 |
Why?
|
Intestinal Diseases | 1 | 2008 | 530 | 0.220 |
Why?
|
Viral Core Proteins | 3 | 2011 | 162 | 0.220 |
Why?
|
Antibodies, Neoplasm | 4 | 1992 | 286 | 0.220 |
Why?
|
Gene Silencing | 2 | 2016 | 1539 | 0.220 |
Why?
|
Reproducibility of Results | 15 | 2023 | 19905 | 0.220 |
Why?
|
Artificial Organs | 3 | 1994 | 204 | 0.220 |
Why?
|
Algorithms | 8 | 2016 | 13882 | 0.220 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2019 | 567 | 0.220 |
Why?
|
Lipid Metabolism | 3 | 2010 | 1889 | 0.220 |
Why?
|
Interferon-gamma | 4 | 2011 | 3207 | 0.220 |
Why?
|
Cytosol | 2 | 2017 | 901 | 0.220 |
Why?
|
Mitochondria | 7 | 2023 | 3514 | 0.220 |
Why?
|
Heparin Antagonists | 1 | 2002 | 32 | 0.210 |
Why?
|
Hepatitis, Chronic | 1 | 2002 | 52 | 0.210 |
Why?
|
Blood Preservation | 1 | 2023 | 177 | 0.210 |
Why?
|
Mice, Nude | 18 | 2014 | 3689 | 0.210 |
Why?
|
Protein Interaction Mapping | 2 | 2007 | 627 | 0.210 |
Why?
|
Cell Respiration | 1 | 2003 | 201 | 0.210 |
Why?
|
Blood Chemical Analysis | 1 | 2004 | 440 | 0.210 |
Why?
|
Dendritic Cells | 1 | 2013 | 2725 | 0.210 |
Why?
|
Organoids | 3 | 2015 | 701 | 0.210 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2017 | 3873 | 0.210 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2765 | 0.210 |
Why?
|
Colon | 1 | 2010 | 1772 | 0.210 |
Why?
|
Colitis | 1 | 2010 | 1170 | 0.210 |
Why?
|
Tin | 5 | 1994 | 13 | 0.210 |
Why?
|
Carbon | 2 | 2007 | 687 | 0.210 |
Why?
|
Oxidative Stress | 5 | 2020 | 3084 | 0.210 |
Why?
|
Lymph Nodes | 3 | 2010 | 3476 | 0.210 |
Why?
|
Oligonucleotides, Antisense | 3 | 2001 | 433 | 0.210 |
Why?
|
Thrombosis | 2 | 2013 | 2968 | 0.210 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 4751 | 0.210 |
Why?
|
Citrus paradisi | 3 | 2011 | 9 | 0.200 |
Why?
|
Oligonucleotide Array Sequence Analysis | 7 | 2009 | 3921 | 0.200 |
Why?
|
Biomedical Research | 2 | 2021 | 3309 | 0.200 |
Why?
|
Antigens | 2 | 2021 | 1466 | 0.200 |
Why?
|
Cytoskeleton | 7 | 2023 | 1185 | 0.200 |
Why?
|
Calcium Channels | 2 | 2011 | 622 | 0.200 |
Why?
|
Growth Substances | 1 | 2004 | 784 | 0.200 |
Why?
|
Shock | 1 | 2004 | 318 | 0.200 |
Why?
|
Models, Theoretical | 7 | 2023 | 3589 | 0.200 |
Why?
|
Micelles | 1 | 2022 | 203 | 0.200 |
Why?
|
Hormones | 2 | 2003 | 889 | 0.200 |
Why?
|
Methylcholanthrene | 2 | 2016 | 29 | 0.200 |
Why?
|
Reactive Oxygen Species | 5 | 2019 | 2076 | 0.200 |
Why?
|
Collagen Type I | 3 | 2015 | 592 | 0.190 |
Why?
|
Polyethylene Glycols | 6 | 2019 | 1182 | 0.190 |
Why?
|
Donor Selection | 2 | 2013 | 201 | 0.190 |
Why?
|
Drug Interactions | 3 | 2022 | 1460 | 0.190 |
Why?
|
Histocytochemistry | 2 | 2013 | 719 | 0.190 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2020 | 143 | 0.190 |
Why?
|
Immunoglobulin G | 15 | 2010 | 4561 | 0.190 |
Why?
|
Sequence Analysis, Protein | 1 | 2002 | 258 | 0.190 |
Why?
|
Oxidation-Reduction | 8 | 2020 | 2184 | 0.190 |
Why?
|
DNA, Recombinant | 2 | 1999 | 476 | 0.190 |
Why?
|
Asialoglycoproteins | 2 | 1997 | 19 | 0.190 |
Why?
|
Tumor Cells, Cultured | 9 | 2001 | 6313 | 0.190 |
Why?
|
Antibody Affinity | 5 | 2006 | 254 | 0.190 |
Why?
|
Sensitivity and Specificity | 9 | 2016 | 14723 | 0.190 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2008 | 2214 | 0.190 |
Why?
|
Central Nervous System | 1 | 2008 | 1357 | 0.190 |
Why?
|
Islets of Langerhans | 3 | 1993 | 1352 | 0.190 |
Why?
|
Gene Transfer Techniques | 6 | 2002 | 1225 | 0.190 |
Why?
|
Citrates | 1 | 2000 | 131 | 0.190 |
Why?
|
Cell Line, Tumor | 9 | 2020 | 16690 | 0.190 |
Why?
|
Acids | 1 | 2001 | 127 | 0.180 |
Why?
|
Thymus Hormones | 1 | 1999 | 1 | 0.180 |
Why?
|
Models, Animal | 6 | 2016 | 2173 | 0.180 |
Why?
|
Porosity | 2 | 2012 | 362 | 0.180 |
Why?
|
Autoimmunity | 1 | 2008 | 1350 | 0.180 |
Why?
|
Electric Impedance | 3 | 2014 | 729 | 0.180 |
Why?
|
Adjuvants, Immunologic | 1 | 2005 | 1000 | 0.180 |
Why?
|
DNA Primers | 4 | 2008 | 2891 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2018 | 10943 | 0.180 |
Why?
|
Equipment Failure Analysis | 4 | 2010 | 868 | 0.180 |
Why?
|
Haptoglobins | 2 | 2020 | 165 | 0.180 |
Why?
|
Cytochrome P-450 CYP3A | 1 | 2020 | 115 | 0.180 |
Why?
|
Transcription Factors | 10 | 2014 | 12207 | 0.170 |
Why?
|
Cicatrix | 2 | 2016 | 764 | 0.170 |
Why?
|
PPAR gamma | 3 | 2011 | 493 | 0.170 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2019 | 90 | 0.170 |
Why?
|
Cattle | 9 | 2007 | 3922 | 0.170 |
Why?
|
Stem Cell Niche | 2 | 2013 | 346 | 0.170 |
Why?
|
Diffuse Axonal Injury | 1 | 2019 | 49 | 0.170 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 2 | 2009 | 30 | 0.170 |
Why?
|
Xenobiotics | 2 | 2018 | 73 | 0.170 |
Why?
|
Bile Ducts | 1 | 2020 | 284 | 0.170 |
Why?
|
Laminin | 4 | 2015 | 419 | 0.170 |
Why?
|
Cold Ischemia | 2 | 2019 | 65 | 0.170 |
Why?
|
Fluoresceins | 6 | 2008 | 235 | 0.170 |
Why?
|
Glycosaminoglycans | 2 | 1999 | 624 | 0.170 |
Why?
|
Radiation-Sensitizing Agents | 3 | 1996 | 358 | 0.170 |
Why?
|
Enzyme Induction | 4 | 2022 | 475 | 0.170 |
Why?
|
HMGB1 Protein | 1 | 2020 | 134 | 0.170 |
Why?
|
Antibody Specificity | 7 | 1991 | 1095 | 0.170 |
Why?
|
Metalloporphyrins | 3 | 1998 | 41 | 0.170 |
Why?
|
Endotoxemia | 2 | 2010 | 207 | 0.170 |
Why?
|
Neural Pathways | 1 | 2010 | 2974 | 0.170 |
Why?
|
Dimethyl Sulfoxide | 6 | 1993 | 249 | 0.160 |
Why?
|
Dynamins | 1 | 2019 | 152 | 0.160 |
Why?
|
Stress, Mechanical | 4 | 2013 | 1686 | 0.160 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2004 | 719 | 0.160 |
Why?
|
Mitosis | 1 | 2004 | 1208 | 0.160 |
Why?
|
Hepatic Stellate Cells | 2 | 2016 | 109 | 0.160 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2014 | 1159 | 0.160 |
Why?
|
Intestinal Absorption | 5 | 2012 | 420 | 0.160 |
Why?
|
Indoleacetic Acids | 1 | 2018 | 44 | 0.160 |
Why?
|
Nucleotidyltransferases | 1 | 2020 | 220 | 0.160 |
Why?
|
Tachycardia | 1 | 2020 | 619 | 0.160 |
Why?
|
Lac Operon | 5 | 1999 | 238 | 0.160 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2020 | 161 | 0.160 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2020 | 1736 | 0.160 |
Why?
|
Amiodarone | 1 | 2019 | 212 | 0.160 |
Why?
|
Adaptation, Physiological | 4 | 2017 | 1312 | 0.160 |
Why?
|
Tryptamines | 1 | 2018 | 88 | 0.160 |
Why?
|
Immunologic Factors | 1 | 2007 | 1580 | 0.150 |
Why?
|
Cell Membrane Permeability | 5 | 2014 | 590 | 0.150 |
Why?
|
Rifampin | 1 | 2019 | 315 | 0.150 |
Why?
|
Tretinoin | 2 | 2011 | 517 | 0.150 |
Why?
|
Hydrogels | 2 | 2021 | 724 | 0.150 |
Why?
|
Cell Line, Transformed | 2 | 2011 | 898 | 0.150 |
Why?
|
Permeability | 5 | 2014 | 738 | 0.150 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 1031 | 0.150 |
Why?
|
Nerve Net | 1 | 2010 | 2175 | 0.150 |
Why?
|
Extracellular Matrix Proteins | 2 | 2014 | 850 | 0.150 |
Why?
|
Satiety Response | 1 | 2017 | 49 | 0.150 |
Why?
|
Leukocytes | 3 | 2011 | 2045 | 0.150 |
Why?
|
Cell Count | 5 | 2013 | 1856 | 0.150 |
Why?
|
Isotopes | 1 | 1997 | 124 | 0.150 |
Why?
|
Drug Combinations | 4 | 2015 | 1958 | 0.150 |
Why?
|
Motor Activity | 1 | 2007 | 2715 | 0.150 |
Why?
|
Immunity, Innate | 1 | 2009 | 2962 | 0.150 |
Why?
|
Carbohydrate Metabolism | 1 | 2018 | 265 | 0.150 |
Why?
|
Prefrontal Cortex | 1 | 2007 | 2147 | 0.150 |
Why?
|
Membrane Proteins | 3 | 2010 | 7882 | 0.140 |
Why?
|
Antigens, Neoplasm | 8 | 1994 | 1988 | 0.140 |
Why?
|
Nylons | 2 | 2014 | 47 | 0.140 |
Why?
|
Therapeutics | 1 | 1997 | 116 | 0.140 |
Why?
|
Bilirubin | 2 | 2009 | 425 | 0.140 |
Why?
|
Metabolic Diseases | 1 | 2003 | 658 | 0.140 |
Why?
|
Gels | 5 | 2015 | 427 | 0.140 |
Why?
|
Environment | 2 | 2011 | 1123 | 0.140 |
Why?
|
Diffusion | 4 | 2012 | 832 | 0.140 |
Why?
|
Cations | 3 | 2007 | 232 | 0.140 |
Why?
|
Fluorescent Dyes | 3 | 2021 | 1917 | 0.140 |
Why?
|
Adoptive Transfer | 2 | 2010 | 844 | 0.140 |
Why?
|
Ferric Compounds | 1 | 2018 | 374 | 0.140 |
Why?
|
Nucleic Acids | 1 | 1999 | 182 | 0.140 |
Why?
|
Magnetite Nanoparticles | 1 | 2018 | 321 | 0.140 |
Why?
|
Recombinant Proteins | 7 | 2021 | 6621 | 0.140 |
Why?
|
Cell Hypoxia | 3 | 2015 | 675 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2011 | 1284 | 0.140 |
Why?
|
Rabbits | 14 | 1999 | 4894 | 0.140 |
Why?
|
U937 Cells | 2 | 2006 | 268 | 0.140 |
Why?
|
Microscopy, Fluorescence | 6 | 2014 | 2700 | 0.140 |
Why?
|
Connective Tissue Growth Factor | 1 | 2016 | 96 | 0.140 |
Why?
|
Tryptophan | 1 | 2018 | 478 | 0.140 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1999 | 547 | 0.140 |
Why?
|
Adsorption | 5 | 2002 | 201 | 0.140 |
Why?
|
Liver Neoplasms | 3 | 2008 | 4253 | 0.130 |
Why?
|
Neoplasms | 7 | 2014 | 21696 | 0.130 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2017 | 271 | 0.130 |
Why?
|
RNA, Small Interfering | 2 | 2016 | 3505 | 0.130 |
Why?
|
Microtubules | 4 | 2023 | 1089 | 0.130 |
Why?
|
Tissue and Organ Procurement | 1 | 2004 | 896 | 0.130 |
Why?
|
Swine | 8 | 2013 | 5918 | 0.130 |
Why?
|
Mass Spectrometry | 4 | 2009 | 2204 | 0.130 |
Why?
|
Phlebotomy | 1 | 2016 | 141 | 0.130 |
Why?
|
Oncostatin M | 2 | 2008 | 28 | 0.130 |
Why?
|
RNA, Messenger | 11 | 2009 | 13035 | 0.130 |
Why?
|
Hep G2 Cells | 4 | 2018 | 393 | 0.130 |
Why?
|
Flow Cytometry | 6 | 2011 | 5974 | 0.130 |
Why?
|
Bile Acids and Salts | 4 | 2020 | 368 | 0.130 |
Why?
|
Antibodies | 4 | 2011 | 2460 | 0.130 |
Why?
|
Peptide Fragments | 3 | 2021 | 5096 | 0.130 |
Why?
|
Hydrostatic Pressure | 3 | 2000 | 106 | 0.130 |
Why?
|
Electromagnetic Phenomena | 1 | 2016 | 161 | 0.130 |
Why?
|
Immunoglobulins | 4 | 1990 | 881 | 0.130 |
Why?
|
Resuscitation | 1 | 2020 | 658 | 0.130 |
Why?
|
Systems Integration | 2 | 2007 | 440 | 0.130 |
Why?
|
Electric Stimulation | 2 | 2011 | 1767 | 0.130 |
Why?
|
Genes, Reporter | 5 | 2017 | 1547 | 0.130 |
Why?
|
Adipose Tissue | 2 | 2019 | 3280 | 0.130 |
Why?
|
Bacteriolysis | 1 | 1994 | 51 | 0.130 |
Why?
|
Sebaceous Glands | 1 | 2014 | 41 | 0.130 |
Why?
|
Neovascularization, Physiologic | 4 | 2020 | 1351 | 0.120 |
Why?
|
Electrochemotherapy | 1 | 2014 | 7 | 0.120 |
Why?
|
Thymus Gland | 1 | 1999 | 1267 | 0.120 |
Why?
|
Melanoma, Experimental | 4 | 1992 | 561 | 0.120 |
Why?
|
Lasers | 4 | 2008 | 952 | 0.120 |
Why?
|
Intercellular Signaling Peptides and Proteins | 5 | 2015 | 1677 | 0.120 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2014 | 424 | 0.120 |
Why?
|
Laser Coagulation | 1 | 1997 | 326 | 0.120 |
Why?
|
Partial Pressure | 3 | 2006 | 254 | 0.120 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1613 | 0.120 |
Why?
|
Chlorophyllides | 4 | 1996 | 53 | 0.120 |
Why?
|
Adenoviridae | 3 | 2011 | 1101 | 0.120 |
Why?
|
Hypoglycemic Agents | 3 | 2016 | 2873 | 0.120 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2023 | 2540 | 0.120 |
Why?
|
Materials Testing | 3 | 2019 | 867 | 0.120 |
Why?
|
DNA, Antisense | 1 | 1994 | 46 | 0.120 |
Why?
|
Bacterial Load | 1 | 2015 | 153 | 0.120 |
Why?
|
Acetyl Coenzyme A | 1 | 2014 | 74 | 0.120 |
Why?
|
Contracture | 1 | 1997 | 224 | 0.120 |
Why?
|
History, 18th Century | 2 | 2014 | 213 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2005 | 12244 | 0.120 |
Why?
|
Genetic Techniques | 1 | 1997 | 435 | 0.120 |
Why?
|
Mannose-Binding Lectins | 1 | 2014 | 100 | 0.120 |
Why?
|
Trehalose | 2 | 2011 | 88 | 0.120 |
Why?
|
Hemoglobins | 1 | 2020 | 1532 | 0.120 |
Why?
|
Protein Array Analysis | 2 | 2007 | 411 | 0.120 |
Why?
|
Organ Specificity | 4 | 2010 | 2008 | 0.120 |
Why?
|
Calcium Signaling | 1 | 1998 | 721 | 0.120 |
Why?
|
Proteomics | 4 | 2015 | 3638 | 0.120 |
Why?
|
Chemokine CXCL12 | 1 | 2016 | 465 | 0.120 |
Why?
|
Immune Tolerance | 3 | 2008 | 2259 | 0.120 |
Why?
|
Fatty Acids | 5 | 2020 | 1809 | 0.120 |
Why?
|
Protein Binding | 4 | 2014 | 9384 | 0.120 |
Why?
|
NAD | 1 | 2017 | 590 | 0.120 |
Why?
|
Tissue Distribution | 8 | 2013 | 2327 | 0.120 |
Why?
|
Enkephalins | 1 | 2014 | 154 | 0.120 |
Why?
|
Mice, Inbred BALB C | 9 | 2019 | 6386 | 0.120 |
Why?
|
Fatty Acids, Nonesterified | 2 | 2023 | 402 | 0.120 |
Why?
|
Drug Delivery Systems | 5 | 2016 | 2219 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2006 | 4386 | 0.120 |
Why?
|
Fibrinogen | 3 | 2009 | 894 | 0.120 |
Why?
|
HSP70 Heat-Shock Proteins | 2 | 2006 | 404 | 0.110 |
Why?
|
Hepatocyte Growth Factor | 2 | 2006 | 270 | 0.110 |
Why?
|
Needles | 1 | 2016 | 449 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3511 | 0.110 |
Why?
|
Metabolomics | 2 | 2020 | 1485 | 0.110 |
Why?
|
Indium Radioisotopes | 2 | 1991 | 118 | 0.110 |
Why?
|
Models, Immunological | 2 | 2007 | 527 | 0.110 |
Why?
|
Microscopy, Phase-Contrast | 3 | 2006 | 115 | 0.110 |
Why?
|
Online Systems | 1 | 1994 | 184 | 0.110 |
Why?
|
Melanoma | 6 | 2013 | 5511 | 0.110 |
Why?
|
Erythrocytes | 2 | 2023 | 2455 | 0.110 |
Why?
|
Molecular Weight | 8 | 2001 | 2255 | 0.110 |
Why?
|
Carnitine | 1 | 2014 | 246 | 0.110 |
Why?
|
Dipeptidyl Peptidase 4 | 2 | 2008 | 91 | 0.110 |
Why?
|
Calcium Channel Blockers | 2 | 2011 | 692 | 0.110 |
Why?
|
Bile | 2 | 2011 | 299 | 0.110 |
Why?
|
Body Temperature | 2 | 2013 | 777 | 0.110 |
Why?
|
Contractile Proteins | 1 | 2014 | 246 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2008 | 18111 | 0.110 |
Why?
|
Animal Testing Alternatives | 1 | 2012 | 14 | 0.110 |
Why?
|
Equipment and Supplies | 1 | 2015 | 281 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 4554 | 0.110 |
Why?
|
Immunoglobulin Fragments | 1 | 1992 | 84 | 0.110 |
Why?
|
Polyribosomes | 1 | 1992 | 110 | 0.110 |
Why?
|
Water | 2 | 2018 | 1395 | 0.110 |
Why?
|
Cadherins | 3 | 2011 | 907 | 0.110 |
Why?
|
Actins | 7 | 2023 | 2121 | 0.110 |
Why?
|
Hydrocortisone | 4 | 2003 | 1826 | 0.110 |
Why?
|
Ammonia | 2 | 2004 | 239 | 0.110 |
Why?
|
Thioacetamide | 1 | 2012 | 15 | 0.110 |
Why?
|
Platelet-Derived Growth Factor | 4 | 2001 | 625 | 0.110 |
Why?
|
Molecular Structure | 4 | 2011 | 1899 | 0.110 |
Why?
|
Models, Molecular | 5 | 2014 | 5451 | 0.110 |
Why?
|
Nitric Oxide | 3 | 2007 | 2132 | 0.100 |
Why?
|
History, 19th Century | 2 | 2014 | 720 | 0.100 |
Why?
|
Amino Acid Sequence | 5 | 2008 | 13814 | 0.100 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 2005 | 370 | 0.100 |
Why?
|
Spectrophotometry | 2 | 2008 | 313 | 0.100 |
Why?
|
Focal Infection | 1 | 1991 | 9 | 0.100 |
Why?
|
Transcriptional Activation | 2 | 2016 | 1783 | 0.100 |
Why?
|
Administration, Cutaneous | 1 | 2014 | 711 | 0.100 |
Why?
|
Transgenes | 2 | 2008 | 1009 | 0.100 |
Why?
|
Purinergic Antagonists | 1 | 2011 | 11 | 0.100 |
Why?
|
Receptors, Ionotropic Glutamate | 1 | 2011 | 9 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 2 | 2012 | 3390 | 0.100 |
Why?
|
Desiccation | 1 | 2011 | 71 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
Diptera | 1 | 2011 | 53 | 0.100 |
Why?
|
Housing, Animal | 1 | 2011 | 48 | 0.100 |
Why?
|
Rats, Inbred Strains | 7 | 1992 | 2186 | 0.100 |
Why?
|
Lipoproteins, LDL | 3 | 1989 | 640 | 0.100 |
Why?
|
Cells, Immobilized | 1 | 2011 | 36 | 0.100 |
Why?
|
Drugs, Investigational | 1 | 2013 | 214 | 0.100 |
Why?
|
Hepatectomy | 2 | 2012 | 550 | 0.100 |
Why?
|
Tin Compounds | 1 | 1991 | 8 | 0.100 |
Why?
|
Receptors, Purinergic | 1 | 2011 | 66 | 0.100 |
Why?
|
Interleukin-8 | 1 | 2014 | 690 | 0.100 |
Why?
|
Protein Precursors | 2 | 2014 | 1154 | 0.100 |
Why?
|
Gases | 1 | 2012 | 197 | 0.100 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2013 | 876 | 0.100 |
Why?
|
beta-Cyclodextrins | 1 | 2011 | 64 | 0.100 |
Why?
|
Jejunum | 1 | 2013 | 480 | 0.100 |
Why?
|
Kupffer Cells | 2 | 2013 | 142 | 0.100 |
Why?
|
Hair | 1 | 2014 | 481 | 0.100 |
Why?
|
Ribonuclease, Pancreatic | 1 | 1992 | 154 | 0.100 |
Why?
|
Light | 7 | 1995 | 1374 | 0.100 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2008 | 1723 | 0.100 |
Why?
|
Transplantation Immunology | 1 | 2013 | 546 | 0.100 |
Why?
|
Cell Polarity | 2 | 2009 | 645 | 0.100 |
Why?
|
Veratrum Alkaloids | 1 | 2010 | 25 | 0.100 |
Why?
|
Trinitrobenzenesulfonic Acid | 1 | 2010 | 68 | 0.100 |
Why?
|
Biofilms | 1 | 2015 | 617 | 0.100 |
Why?
|
Lectins, C-Type | 1 | 2014 | 589 | 0.100 |
Why?
|
Gastroplasty | 1 | 2012 | 142 | 0.100 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 2 | 2002 | 57 | 0.100 |
Why?
|
Static Electricity | 2 | 2004 | 263 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2949 | 0.100 |
Why?
|
History of Medicine | 1 | 2011 | 35 | 0.100 |
Why?
|
Flow Injection Analysis | 2 | 2007 | 22 | 0.090 |
Why?
|
SOXB1 Transcription Factors | 2 | 2013 | 284 | 0.090 |
Why?
|
Hydrogen Bonding | 1 | 2011 | 291 | 0.090 |
Why?
|
Mesoderm | 2 | 2007 | 686 | 0.090 |
Why?
|
Hybrid Cells | 2 | 1981 | 441 | 0.090 |
Why?
|
Cytological Techniques | 2 | 2011 | 219 | 0.090 |
Why?
|
Pattern Recognition, Automated | 2 | 2014 | 1005 | 0.090 |
Why?
|
Interleukin-4 | 1 | 2014 | 1147 | 0.090 |
Why?
|
CHO Cells | 2 | 2011 | 1409 | 0.090 |
Why?
|
Postoperative Period | 2 | 2007 | 1842 | 0.090 |
Why?
|
History, Ancient | 1 | 2011 | 212 | 0.090 |
Why?
|
Random Allocation | 3 | 2016 | 2428 | 0.090 |
Why?
|
Orphan Nuclear Receptors | 1 | 2010 | 60 | 0.090 |
Why?
|
Sodium Channel Blockers | 1 | 2011 | 176 | 0.090 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 64 | 0.090 |
Why?
|
Virus Assembly | 1 | 2011 | 144 | 0.090 |
Why?
|
Receptors, Death Domain | 1 | 2010 | 32 | 0.090 |
Why?
|
Mice, Knockout | 8 | 2020 | 14561 | 0.090 |
Why?
|
Compressive Strength | 1 | 2011 | 169 | 0.090 |
Why?
|
Insect Proteins | 1 | 2011 | 258 | 0.090 |
Why?
|
Ultrasonography | 2 | 2014 | 5984 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 2 | 2013 | 783 | 0.090 |
Why?
|
Gastrectomy | 1 | 2015 | 663 | 0.090 |
Why?
|
Phototherapy | 2 | 1991 | 377 | 0.090 |
Why?
|
Axons | 2 | 2022 | 1685 | 0.090 |
Why?
|
Anti-Ulcer Agents | 1 | 2011 | 119 | 0.090 |
Why?
|
Muscles | 3 | 2010 | 1614 | 0.090 |
Why?
|
Analysis of Variance | 4 | 2012 | 6366 | 0.090 |
Why?
|
Lactic Acid | 3 | 2020 | 1132 | 0.090 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2011 | 440 | 0.090 |
Why?
|
Base Sequence | 6 | 2008 | 12797 | 0.090 |
Why?
|
Autoradiography | 5 | 1991 | 745 | 0.090 |
Why?
|
Interleukin-18 | 1 | 2011 | 249 | 0.090 |
Why?
|
Microscopy | 2 | 1997 | 902 | 0.090 |
Why?
|
Antigen-Antibody Reactions | 2 | 1992 | 363 | 0.090 |
Why?
|
Cell Extracts | 1 | 2010 | 138 | 0.090 |
Why?
|
3T3-L1 Cells | 1 | 2010 | 199 | 0.090 |
Why?
|
Reference Values | 4 | 2016 | 4982 | 0.090 |
Why?
|
Hindlimb | 3 | 2004 | 504 | 0.090 |
Why?
|
Mice, Inbred Strains | 5 | 2005 | 1828 | 0.090 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2011 | 211 | 0.090 |
Why?
|
Ethanol | 1 | 2016 | 1342 | 0.090 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2011 | 534 | 0.090 |
Why?
|
Protein Multimerization | 1 | 2014 | 971 | 0.090 |
Why?
|
Sodium Channels | 1 | 2011 | 349 | 0.090 |
Why?
|
Glutathione | 3 | 2019 | 590 | 0.090 |
Why?
|
Silver | 1 | 2010 | 122 | 0.090 |
Why?
|
Cellular Structures | 1 | 2009 | 11 | 0.090 |
Why?
|
Staphylococcal Protein A | 1 | 1989 | 40 | 0.090 |
Why?
|
Bioengineering | 1 | 2010 | 99 | 0.090 |
Why?
|
HeLa Cells | 3 | 2012 | 3130 | 0.090 |
Why?
|
Receptors, Cell Surface | 2 | 2020 | 2865 | 0.090 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 310 | 0.090 |
Why?
|
Cell Tracking | 1 | 2010 | 145 | 0.090 |
Why?
|
Drug Carriers | 3 | 2002 | 693 | 0.090 |
Why?
|
Social Environment | 3 | 2011 | 1022 | 0.080 |
Why?
|
Response Elements | 2 | 2010 | 312 | 0.080 |
Why?
|
Fluorescence Polarization | 2 | 1999 | 132 | 0.080 |
Why?
|
HIV | 1 | 2016 | 1604 | 0.080 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2008 | 68 | 0.080 |
Why?
|
Muramidase | 2 | 1999 | 174 | 0.080 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2010 | 197 | 0.080 |
Why?
|
Food Preferences | 1 | 2012 | 399 | 0.080 |
Why?
|
Databases, Protein | 1 | 2011 | 383 | 0.080 |
Why?
|
Survival Rate | 5 | 2014 | 12788 | 0.080 |
Why?
|
Galactosyltransferases | 1 | 2010 | 264 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2010 | 712 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2003 | 2775 | 0.080 |
Why?
|
Transplantation, Heterologous | 4 | 2008 | 2383 | 0.080 |
Why?
|
Reverse Transcription | 1 | 2008 | 47 | 0.080 |
Why?
|
Binding, Competitive | 6 | 1996 | 1157 | 0.080 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5749 | 0.080 |
Why?
|
Quartz | 1 | 2008 | 24 | 0.080 |
Why?
|
Photochemistry | 3 | 1995 | 238 | 0.080 |
Why?
|
Molecular Dynamics Simulation | 1 | 2011 | 409 | 0.080 |
Why?
|
Nitric Oxide Synthase | 1 | 2011 | 915 | 0.080 |
Why?
|
Phantoms, Imaging | 1 | 2016 | 2480 | 0.080 |
Why?
|
Necrosis | 1 | 2012 | 1643 | 0.080 |
Why?
|
Brain Concussion | 1 | 2019 | 1320 | 0.080 |
Why?
|
E-Selectin | 1 | 2010 | 579 | 0.080 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 1629 | 0.080 |
Why?
|
Viral Proteins | 2 | 2008 | 1900 | 0.080 |
Why?
|
Intracellular Space | 1 | 2009 | 212 | 0.080 |
Why?
|
Prostatic Neoplasms | 2 | 2010 | 11126 | 0.080 |
Why?
|
Micromanipulation | 1 | 2008 | 53 | 0.080 |
Why?
|
Electrophoresis | 1 | 1988 | 240 | 0.080 |
Why?
|
Lymphocytes | 4 | 2002 | 2617 | 0.080 |
Why?
|
Models, Statistical | 4 | 2015 | 5101 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3524 | 0.080 |
Why?
|
Nanostructures | 2 | 2016 | 551 | 0.080 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2010 | 707 | 0.080 |
Why?
|
Circular Dichroism | 1 | 2008 | 354 | 0.080 |
Why?
|
Scattering, Radiation | 5 | 1991 | 498 | 0.080 |
Why?
|
Homozygote | 3 | 2009 | 1787 | 0.080 |
Why?
|
Thiazolidinediones | 1 | 2011 | 476 | 0.080 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2008 | 126 | 0.080 |
Why?
|
Multienzyme Complexes | 3 | 2007 | 686 | 0.080 |
Why?
|
Skin Transplantation | 3 | 1998 | 1074 | 0.080 |
Why?
|
Acrylic Resins | 1 | 2008 | 142 | 0.080 |
Why?
|
Raffinose | 2 | 2019 | 52 | 0.080 |
Why?
|
Fasting | 2 | 2010 | 1592 | 0.080 |
Why?
|
Embryonic Induction | 1 | 2007 | 149 | 0.080 |
Why?
|
Viscosity | 3 | 2018 | 328 | 0.080 |
Why?
|
Models, Genetic | 3 | 2008 | 3493 | 0.080 |
Why?
|
Phenotype | 4 | 2014 | 16367 | 0.080 |
Why?
|
Heart Valves | 1 | 1989 | 291 | 0.070 |
Why?
|
High Mobility Group Proteins | 1 | 2008 | 187 | 0.070 |
Why?
|
Neuroglia | 1 | 2013 | 928 | 0.070 |
Why?
|
Promoter Regions, Genetic | 2 | 2009 | 5867 | 0.070 |
Why?
|
Polymerase Chain Reaction | 3 | 2023 | 6171 | 0.070 |
Why?
|
Radioimmunoassay | 4 | 1994 | 919 | 0.070 |
Why?
|
Tissue Array Analysis | 1 | 2009 | 553 | 0.070 |
Why?
|
Deltaretrovirus Infections | 1 | 1986 | 26 | 0.070 |
Why?
|
Chemokines | 2 | 2011 | 970 | 0.070 |
Why?
|
Antigen Presentation | 2 | 2010 | 1284 | 0.070 |
Why?
|
Binding Sites, Antibody | 3 | 1992 | 349 | 0.070 |
Why?
|
Animals, Newborn | 2 | 2012 | 2726 | 0.070 |
Why?
|
Shock, Septic | 1 | 2014 | 775 | 0.070 |
Why?
|
Miniaturization | 1 | 2007 | 164 | 0.070 |
Why?
|
Follistatin | 1 | 2007 | 141 | 0.070 |
Why?
|
Cartilage | 1 | 2011 | 818 | 0.070 |
Why?
|
Neutrophils | 4 | 2012 | 3721 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2014 | 4851 | 0.070 |
Why?
|
Superoxides | 1 | 2008 | 387 | 0.070 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2008 | 297 | 0.070 |
Why?
|
History, 20th Century | 2 | 2014 | 2740 | 0.070 |
Why?
|
Neurites | 1 | 2008 | 388 | 0.070 |
Why?
|
Microarray Analysis | 1 | 2009 | 767 | 0.070 |
Why?
|
Neoplasm Transplantation | 5 | 2014 | 2086 | 0.070 |
Why?
|
Cell Shape | 1 | 2007 | 375 | 0.070 |
Why?
|
Radiography | 2 | 2013 | 7023 | 0.070 |
Why?
|
Melanins | 1 | 2008 | 289 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2014 | 4208 | 0.070 |
Why?
|
Interleukin-2 | 1 | 1993 | 1904 | 0.070 |
Why?
|
Ligation | 1 | 2007 | 453 | 0.070 |
Why?
|
Osmolar Concentration | 3 | 1999 | 683 | 0.070 |
Why?
|
Binding Sites | 3 | 2011 | 6111 | 0.070 |
Why?
|
Thalamus | 1 | 2012 | 1023 | 0.070 |
Why?
|
Gastroenterology | 1 | 2012 | 538 | 0.070 |
Why?
|
Docosahexaenoic Acids | 1 | 2012 | 875 | 0.070 |
Why?
|
Allopurinol | 2 | 2019 | 191 | 0.070 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2005 | 49 | 0.070 |
Why?
|
Peptide Library | 1 | 2007 | 349 | 0.070 |
Why?
|
Hemopexin | 1 | 2005 | 33 | 0.070 |
Why?
|
Biological Evolution | 1 | 2011 | 1077 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1888 | 0.070 |
Why?
|
Immunoglobulin Light Chains | 4 | 1981 | 277 | 0.070 |
Why?
|
Models, Chemical | 1 | 2008 | 626 | 0.070 |
Why?
|
Brain | 2 | 2011 | 26388 | 0.070 |
Why?
|
Mechanotransduction, Cellular | 2 | 2008 | 541 | 0.060 |
Why?
|
Calcium | 1 | 1998 | 5755 | 0.060 |
Why?
|
Connective Tissue | 2 | 1999 | 420 | 0.060 |
Why?
|
Rats, Long-Evans | 3 | 2013 | 387 | 0.060 |
Why?
|
Oxytocin | 1 | 2009 | 394 | 0.060 |
Why?
|
Mathematics | 4 | 1994 | 728 | 0.060 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2005 | 171 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.060 |
Why?
|
Wounds, Penetrating | 1 | 2007 | 307 | 0.060 |
Why?
|
Acoustics | 2 | 2017 | 240 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2016 | 11366 | 0.060 |
Why?
|
History, 21st Century | 1 | 2011 | 1534 | 0.060 |
Why?
|
Cell Nucleus | 1 | 2013 | 2969 | 0.060 |
Why?
|
Genome, Viral | 1 | 2008 | 667 | 0.060 |
Why?
|
Lipocalins | 1 | 2005 | 170 | 0.060 |
Why?
|
Chemical Phenomena | 3 | 1990 | 518 | 0.060 |
Why?
|
Body Surface Area | 3 | 2010 | 199 | 0.060 |
Why?
|
Integrin alpha6 | 2 | 2014 | 30 | 0.060 |
Why?
|
Biological Assay | 1 | 2007 | 652 | 0.060 |
Why?
|
Cholesterol | 3 | 2013 | 2919 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 483 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1525 | 0.060 |
Why?
|
Brain Chemistry | 1 | 2007 | 982 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2016 | 2657 | 0.060 |
Why?
|
Virion | 1 | 2006 | 433 | 0.060 |
Why?
|
Survival Analysis | 2 | 2009 | 10252 | 0.060 |
Why?
|
Pharmacokinetics | 3 | 2012 | 88 | 0.060 |
Why?
|
Proton-Translocating ATPases | 1 | 2004 | 116 | 0.060 |
Why?
|
Endothelium, Vascular | 1 | 1996 | 4459 | 0.060 |
Why?
|
Oligomycins | 1 | 2003 | 19 | 0.060 |
Why?
|
Antimycin A | 1 | 2003 | 30 | 0.060 |
Why?
|
Positron-Emission Tomography | 3 | 2014 | 6234 | 0.060 |
Why?
|
Antibodies, Anti-Idiotypic | 3 | 1985 | 349 | 0.060 |
Why?
|
Death | 1 | 2008 | 678 | 0.060 |
Why?
|
Plasmids | 1 | 2008 | 2308 | 0.060 |
Why?
|
Linear Models | 1 | 2013 | 5953 | 0.060 |
Why?
|
Radionuclide Imaging | 4 | 1992 | 2031 | 0.060 |
Why?
|
Phosphorylation | 1 | 2014 | 8436 | 0.060 |
Why?
|
Tissue Survival | 2 | 2019 | 118 | 0.060 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1994 | 1354 | 0.060 |
Why?
|
Embryonic Development | 1 | 2008 | 711 | 0.060 |
Why?
|
Vesicular Transport Proteins | 1 | 2006 | 377 | 0.060 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2004 | 121 | 0.060 |
Why?
|
Hyperthermia, Induced | 1 | 2006 | 403 | 0.060 |
Why?
|
Immunoprecipitation | 1 | 2005 | 906 | 0.060 |
Why?
|
Down-Regulation | 2 | 2010 | 3001 | 0.050 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2006 | 555 | 0.050 |
Why?
|
Epitopes | 3 | 1987 | 2571 | 0.050 |
Why?
|
Phagocytosis | 1 | 2008 | 1539 | 0.050 |
Why?
|
Basal Metabolism | 1 | 2003 | 168 | 0.050 |
Why?
|
Heterozygote | 1 | 2009 | 2804 | 0.050 |
Why?
|
Cell Division | 5 | 2001 | 4569 | 0.050 |
Why?
|
Lipolysis | 1 | 2003 | 210 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2016 | 4042 | 0.050 |
Why?
|
Antibodies, Bacterial | 5 | 2014 | 1470 | 0.050 |
Why?
|
Adenosine | 2 | 2019 | 825 | 0.050 |
Why?
|
Biomedical Technology | 1 | 2004 | 220 | 0.050 |
Why?
|
Neoplasm Proteins | 2 | 1994 | 3707 | 0.050 |
Why?
|
Immunoglobulin kappa-Chains | 5 | 1985 | 173 | 0.050 |
Why?
|
Biological Availability | 2 | 2014 | 397 | 0.050 |
Why?
|
Discriminant Analysis | 2 | 2012 | 235 | 0.050 |
Why?
|
Feedback | 1 | 2005 | 795 | 0.050 |
Why?
|
Antigens, CD34 | 2 | 2014 | 659 | 0.050 |
Why?
|
Poloxamer | 1 | 2001 | 57 | 0.050 |
Why?
|
Lymphocyte Activation | 3 | 2011 | 5524 | 0.050 |
Why?
|
Molecular Chaperones | 1 | 2006 | 743 | 0.050 |
Why?
|
Gadolinium | 1 | 2006 | 952 | 0.050 |
Why?
|
Least-Squares Analysis | 2 | 2012 | 379 | 0.050 |
Why?
|
RNA | 2 | 2007 | 2749 | 0.050 |
Why?
|
Cross-Linking Reagents | 2 | 1997 | 694 | 0.050 |
Why?
|
Phenobarbital | 1 | 2001 | 193 | 0.050 |
Why?
|
Glutathione Reductase | 1 | 2000 | 25 | 0.050 |
Why?
|
Nucleic Acid Conformation | 2 | 2002 | 913 | 0.050 |
Why?
|
Behavior, Animal | 1 | 2009 | 1881 | 0.050 |
Why?
|
Epidermal Growth Factor | 1 | 2004 | 709 | 0.050 |
Why?
|
Fetal Blood | 1 | 2007 | 1318 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2010 | 2418 | 0.050 |
Why?
|
Isomerism | 2 | 1999 | 201 | 0.050 |
Why?
|
Biological Transport | 3 | 2011 | 2120 | 0.050 |
Why?
|
Chromatography, Affinity | 2 | 1992 | 549 | 0.050 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 277 | 0.050 |
Why?
|
Lipids | 1 | 2012 | 3307 | 0.050 |
Why?
|
Immunoglobulin Constant Regions | 1 | 1980 | 60 | 0.050 |
Why?
|
Saccharomyces cerevisiae | 1 | 2011 | 2751 | 0.050 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 1980 | 659 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2005 | 1081 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2008 | 9647 | 0.050 |
Why?
|
Trans-Activators | 1 | 2010 | 2926 | 0.050 |
Why?
|
Immunodominant Epitopes | 1 | 2021 | 267 | 0.050 |
Why?
|
Blood Glucose | 2 | 2013 | 6254 | 0.050 |
Why?
|
Tumor Microenvironment | 1 | 2012 | 3590 | 0.050 |
Why?
|
Genes, MHC Class I | 1 | 2001 | 258 | 0.050 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 1997 | 361 | 0.050 |
Why?
|
Lipoproteins, VLDL | 2 | 2011 | 201 | 0.050 |
Why?
|
Fibrinolysin | 1 | 2000 | 131 | 0.040 |
Why?
|
Ethylene Glycol | 2 | 2008 | 29 | 0.040 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2013 | 223 | 0.040 |
Why?
|
RNA Interference | 1 | 2009 | 2890 | 0.040 |
Why?
|
Phase Transition | 1 | 2019 | 74 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8432 | 0.040 |
Why?
|
Forecasting | 1 | 2009 | 2951 | 0.040 |
Why?
|
Cathepsins | 1 | 2000 | 241 | 0.040 |
Why?
|
Immunologic Techniques | 2 | 1990 | 219 | 0.040 |
Why?
|
Singlet Oxygen | 2 | 1998 | 53 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2007 | 1837 | 0.040 |
Why?
|
Mice, Obese | 1 | 2020 | 425 | 0.040 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2000 | 207 | 0.040 |
Why?
|
Carbon Radioisotopes | 1 | 2000 | 577 | 0.040 |
Why?
|
Mice, Inbred NOD | 2 | 2014 | 1879 | 0.040 |
Why?
|
Bicarbonates | 1 | 2020 | 313 | 0.040 |
Why?
|
Lipid Peroxides | 1 | 1998 | 73 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 1980 | 421 | 0.040 |
Why?
|
HL-60 Cells | 2 | 2016 | 365 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2017 | 63107 | 0.040 |
Why?
|
Microcirculation | 2 | 2014 | 1287 | 0.040 |
Why?
|
Xanthenes | 1 | 1998 | 73 | 0.040 |
Why?
|
Extracellular Space | 1 | 2001 | 595 | 0.040 |
Why?
|
Suspensions | 1 | 2018 | 65 | 0.040 |
Why?
|
Birefringence | 1 | 1998 | 56 | 0.040 |
Why?
|
Principal Component Analysis | 2 | 2012 | 940 | 0.040 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2020 | 294 | 0.040 |
Why?
|
Alkanes | 1 | 2018 | 45 | 0.040 |
Why?
|
Ubiquitins | 1 | 2000 | 384 | 0.040 |
Why?
|
Crohn Disease | 1 | 2011 | 2304 | 0.040 |
Why?
|
Ion Channels | 1 | 2003 | 1056 | 0.040 |
Why?
|
Carbon Isotopes | 1 | 1999 | 467 | 0.040 |
Why?
|
Oils | 1 | 2018 | 63 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2013 | 3508 | 0.040 |
Why?
|
Alcohols | 1 | 2018 | 92 | 0.040 |
Why?
|
Microscopy, Confocal | 2 | 2012 | 1970 | 0.040 |
Why?
|
Vacuum | 1 | 2018 | 65 | 0.040 |
Why?
|
Antioxidants | 1 | 2006 | 1659 | 0.040 |
Why?
|
Axotomy | 1 | 2018 | 73 | 0.040 |
Why?
|
Dogs | 2 | 2013 | 3912 | 0.040 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2000 | 232 | 0.040 |
Why?
|
Nifedipine | 1 | 1998 | 227 | 0.040 |
Why?
|
Receptors, Fc | 2 | 1992 | 541 | 0.040 |
Why?
|
Chemistry, Physical | 2 | 1988 | 156 | 0.040 |
Why?
|
Verapamil | 1 | 1998 | 244 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 1981 | 548 | 0.040 |
Why?
|
Adult | 8 | 2020 | 214052 | 0.040 |
Why?
|
Nickel | 1 | 1998 | 130 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.040 |
Why?
|
Risk Factors | 3 | 2013 | 72296 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 137 | 0.040 |
Why?
|
Succinates | 1 | 1997 | 82 | 0.040 |
Why?
|
Solubility | 2 | 2011 | 1088 | 0.040 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 2 | 2007 | 164 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2010 | 1369 | 0.040 |
Why?
|
Heme Oxygenase-1 | 1 | 2020 | 381 | 0.040 |
Why?
|
Chromatography, Gel | 1 | 1998 | 668 | 0.040 |
Why?
|
Recombination, Genetic | 2 | 2000 | 1586 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 1999 | 793 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1999 | 906 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.040 |
Why?
|
Retina | 1 | 2008 | 2616 | 0.040 |
Why?
|
Antigens, Surface | 2 | 1993 | 1663 | 0.040 |
Why?
|
Chondroitinases and Chondroitin Lyases | 1 | 1996 | 15 | 0.040 |
Why?
|
Heparin Lyase | 1 | 1996 | 37 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 1997 | 203 | 0.040 |
Why?
|
Prostheses and Implants | 1 | 2004 | 1387 | 0.040 |
Why?
|
Weight Loss | 2 | 2012 | 2625 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2020 | 936 | 0.040 |
Why?
|
Polysaccharide-Lyases | 1 | 1996 | 48 | 0.040 |
Why?
|
Brain Mapping | 1 | 2012 | 6670 | 0.040 |
Why?
|
Evaluation Studies as Topic | 3 | 1994 | 1681 | 0.040 |
Why?
|
Blood Transfusion | 1 | 2023 | 1301 | 0.040 |
Why?
|
Capsid | 1 | 1999 | 437 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2006 | 1790 | 0.040 |
Why?
|
Chickens | 1 | 1998 | 865 | 0.030 |
Why?
|
Nerve Regeneration | 1 | 2022 | 788 | 0.030 |
Why?
|
Rhodamines | 2 | 2013 | 183 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 209 | 0.030 |
Why?
|
Hemodynamics | 2 | 2020 | 4196 | 0.030 |
Why?
|
Patient Selection | 1 | 2008 | 4216 | 0.030 |
Why?
|
Microscopy, Polarization | 1 | 2016 | 88 | 0.030 |
Why?
|
Acute Disease | 1 | 2006 | 7147 | 0.030 |
Why?
|
Ribonucleases | 1 | 1996 | 287 | 0.030 |
Why?
|
Trypsin | 1 | 1996 | 511 | 0.030 |
Why?
|
Disulfides | 1 | 1997 | 457 | 0.030 |
Why?
|
Polypropylenes | 1 | 2015 | 64 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 1996 | 180 | 0.030 |
Why?
|
Mice, Transgenic | 2 | 2016 | 9735 | 0.030 |
Why?
|
Vacuoles | 1 | 1996 | 229 | 0.030 |
Why?
|
Skin Pigmentation | 1 | 1997 | 282 | 0.030 |
Why?
|
Lysosomes | 1 | 2000 | 893 | 0.030 |
Why?
|
Genomics | 2 | 2009 | 5717 | 0.030 |
Why?
|
Deoxyribonucleases | 1 | 1996 | 214 | 0.030 |
Why?
|
Telemetry | 2 | 2009 | 207 | 0.030 |
Why?
|
Ethylenediamines | 1 | 1994 | 48 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2001 | 878 | 0.030 |
Why?
|
Sound | 1 | 2017 | 260 | 0.030 |
Why?
|
Carrier Proteins | 3 | 2011 | 5023 | 0.030 |
Why?
|
Poloxalene | 1 | 1994 | 2 | 0.030 |
Why?
|
Melanoma-Specific Antigens | 2 | 1994 | 80 | 0.030 |
Why?
|
Microscopy, Video | 1 | 1995 | 245 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 2018 | 927 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 1999 | 672 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2017 | 853 | 0.030 |
Why?
|
Epinephrine | 1 | 1998 | 792 | 0.030 |
Why?
|
Glass | 1 | 1994 | 114 | 0.030 |
Why?
|
Free Radicals | 1 | 1994 | 237 | 0.030 |
Why?
|
Saimiri | 3 | 1989 | 330 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2006 | 8642 | 0.030 |
Why?
|
Drug Stability | 1 | 1994 | 291 | 0.030 |
Why?
|
Heparin | 1 | 2001 | 1637 | 0.030 |
Why?
|
Polyurethanes | 1 | 1994 | 107 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2015 | 270 | 0.030 |
Why?
|
Microbial Viability | 1 | 2015 | 234 | 0.030 |
Why?
|
Body Weight | 3 | 2012 | 4671 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2013 | 2016 | 0.030 |
Why?
|
Microscopy, Atomic Force | 1 | 1994 | 250 | 0.030 |
Why?
|
Capillary Permeability | 2 | 2000 | 798 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 20130 | 0.030 |
Why?
|
Intestinal Mucosa | 4 | 2011 | 3037 | 0.030 |
Why?
|
Myocardium | 2 | 2017 | 4772 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2001 | 1837 | 0.030 |
Why?
|
Sutures | 1 | 2016 | 299 | 0.030 |
Why?
|
Biometry | 1 | 1997 | 558 | 0.030 |
Why?
|
Digestion | 1 | 2013 | 54 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2022 | 2307 | 0.030 |
Why?
|
Rosette Formation | 2 | 1985 | 153 | 0.030 |
Why?
|
Fluorocarbons | 1 | 2019 | 452 | 0.030 |
Why?
|
Immunosorbent Techniques | 2 | 1992 | 184 | 0.030 |
Why?
|
Aniline Compounds | 1 | 1998 | 986 | 0.030 |
Why?
|
Cricetinae | 2 | 2011 | 2475 | 0.030 |
Why?
|
Recovery of Function | 1 | 2004 | 2926 | 0.030 |
Why?
|
Hydroxyproline | 1 | 1993 | 116 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2014 | 5077 | 0.030 |
Why?
|
Biliary Tract | 1 | 2014 | 134 | 0.030 |
Why?
|
Luminescent Measurements | 1 | 2015 | 405 | 0.030 |
Why?
|
Bacteremia | 1 | 2000 | 963 | 0.030 |
Why?
|
Phenylhydrazines | 1 | 1992 | 28 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1996 | 494 | 0.030 |
Why?
|
Microvilli | 1 | 1993 | 241 | 0.030 |
Why?
|
Hydrazines | 1 | 1994 | 226 | 0.030 |
Why?
|
Leukemia Virus, Murine | 1 | 1993 | 117 | 0.030 |
Why?
|
Antigens, CD | 2 | 2020 | 4026 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2013 | 193 | 0.030 |
Why?
|
Pepsin A | 1 | 1992 | 71 | 0.030 |
Why?
|
Endopeptidases | 1 | 1996 | 772 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2013 | 356 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 1993 | 246 | 0.030 |
Why?
|
Gene Targeting | 1 | 1996 | 880 | 0.030 |
Why?
|
Lactates | 1 | 2013 | 432 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2014 | 644 | 0.030 |
Why?
|
Stimulation, Chemical | 1 | 1992 | 326 | 0.030 |
Why?
|
Ethanolamines | 1 | 1992 | 158 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1988 | 1801 | 0.030 |
Why?
|
Automation | 1 | 2014 | 584 | 0.030 |
Why?
|
Cell Size | 1 | 1994 | 643 | 0.030 |
Why?
|
Oxygenators, Membrane | 2 | 2002 | 56 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 1997 | 1254 | 0.030 |
Why?
|
Whole-Body Counting | 1 | 1991 | 35 | 0.030 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2014 | 520 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 1995 | 1079 | 0.030 |
Why?
|
Protein Denaturation | 1 | 1992 | 237 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 730 | 0.030 |
Why?
|
Monitoring, Physiologic | 2 | 2002 | 1739 | 0.020 |
Why?
|
Morpholines | 1 | 2014 | 571 | 0.020 |
Why?
|
Brefeldin A | 1 | 2011 | 72 | 0.020 |
Why?
|
Purines | 1 | 2014 | 594 | 0.020 |
Why?
|
Thiocyanates | 1 | 1991 | 70 | 0.020 |
Why?
|
Antifibrinolytic Agents | 1 | 2013 | 254 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2013 | 463 | 0.020 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 727 | 0.020 |
Why?
|
Ablation Techniques | 1 | 2014 | 249 | 0.020 |
Why?
|
Intestines | 2 | 2011 | 1924 | 0.020 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1992 | 482 | 0.020 |
Why?
|
Lymphocyte Subsets | 2 | 2002 | 315 | 0.020 |
Why?
|
Tomography | 1 | 2012 | 390 | 0.020 |
Why?
|
Spinal Cord | 1 | 2019 | 1810 | 0.020 |
Why?
|
Disease Progression | 2 | 2019 | 13286 | 0.020 |
Why?
|
Apolipoprotein B-100 | 1 | 2011 | 148 | 0.020 |
Why?
|
Complement C3a | 1 | 2010 | 69 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1641 | 0.020 |
Why?
|
Urine | 1 | 1992 | 370 | 0.020 |
Why?
|
Chemistry | 1 | 1990 | 352 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2014 | 20824 | 0.020 |
Why?
|
Ethylene Glycols | 1 | 1991 | 156 | 0.020 |
Why?
|
Blotting, Northern | 1 | 1992 | 1581 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2011 | 387 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12746 | 0.020 |
Why?
|
Implants, Experimental | 1 | 2010 | 104 | 0.020 |
Why?
|
Carbohydrates | 1 | 1992 | 394 | 0.020 |
Why?
|
Streptococcus | 3 | 1980 | 197 | 0.020 |
Why?
|
Dietary Fats | 1 | 2018 | 2016 | 0.020 |
Why?
|
Larva | 1 | 2011 | 519 | 0.020 |
Why?
|
Osteopontin | 1 | 2011 | 294 | 0.020 |
Why?
|
Carbohydrate Sequence | 1 | 1990 | 414 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 818 | 0.020 |
Why?
|
Fibronectins | 1 | 1993 | 726 | 0.020 |
Why?
|
Horseradish Peroxidase | 1 | 1989 | 166 | 0.020 |
Why?
|
Rheology | 2 | 2001 | 345 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2716 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 1997 | 3759 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2029 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 2 | 2002 | 1375 | 0.020 |
Why?
|
PPAR alpha | 1 | 2010 | 197 | 0.020 |
Why?
|
Video Recording | 1 | 1994 | 949 | 0.020 |
Why?
|
Viruses | 1 | 1993 | 375 | 0.020 |
Why?
|
Papio | 1 | 2010 | 656 | 0.020 |
Why?
|
Thermal Conductivity | 1 | 2008 | 16 | 0.020 |
Why?
|
Microscopy, Electron | 2 | 1991 | 2646 | 0.020 |
Why?
|
Ascites | 2 | 1981 | 344 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2009 | 862 | 0.020 |
Why?
|
Abdomen | 1 | 1994 | 1118 | 0.020 |
Why?
|
Clinical Laboratory Techniques | 1 | 2014 | 738 | 0.020 |
Why?
|
Propylene Glycol | 1 | 2008 | 32 | 0.020 |
Why?
|
Immunoelectrophoresis | 1 | 1988 | 110 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2010 | 576 | 0.020 |
Why?
|
Complement Activation | 1 | 2010 | 453 | 0.020 |
Why?
|
Buffers | 1 | 1988 | 147 | 0.020 |
Why?
|
Horse Diseases | 1 | 1988 | 57 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1996 | 2016 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2016 | 2007 | 0.020 |
Why?
|
Lysine | 1 | 1993 | 1007 | 0.020 |
Why?
|
Anilides | 1 | 2011 | 408 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2010 | 13693 | 0.020 |
Why?
|
Osmosis | 1 | 2007 | 113 | 0.020 |
Why?
|
Cadaver | 1 | 2011 | 1337 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 758 | 0.020 |
Why?
|
Portal Vein | 1 | 2010 | 437 | 0.020 |
Why?
|
Food | 1 | 2012 | 772 | 0.020 |
Why?
|
Plastics | 1 | 2008 | 123 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2007 | 518 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2001 | 3771 | 0.020 |
Why?
|
Focal Adhesions | 1 | 2007 | 121 | 0.020 |
Why?
|
Ethidium | 1 | 1986 | 27 | 0.020 |
Why?
|
Tendons | 1 | 1991 | 548 | 0.020 |
Why?
|
Shock, Hemorrhagic | 1 | 1988 | 220 | 0.020 |
Why?
|
Endothelium | 1 | 1989 | 778 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2016 | 1862 | 0.020 |
Why?
|
Elasticity | 1 | 2008 | 657 | 0.020 |
Why?
|
Pyridines | 1 | 1997 | 2825 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2008 | 216 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2007 | 454 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2010 | 1537 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2010 | 1169 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2009 | 703 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 1989 | 652 | 0.020 |
Why?
|
Shear Strength | 1 | 2005 | 165 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2008 | 867 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 1992 | 7914 | 0.020 |
Why?
|
Arteries | 1 | 1989 | 1119 | 0.020 |
Why?
|
Bacterial Infections | 1 | 1993 | 1401 | 0.010 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2004 | 107 | 0.010 |
Why?
|
Heart Diseases | 1 | 1997 | 2789 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2022 | 21748 | 0.010 |
Why?
|
Intestine, Small | 1 | 1990 | 1240 | 0.010 |
Why?
|
Pilot Projects | 1 | 1997 | 8319 | 0.010 |
Why?
|
Neutrophil Activation | 1 | 2004 | 186 | 0.010 |
Why?
|
Methionine | 2 | 1990 | 590 | 0.010 |
Why?
|
Computer-Aided Design | 1 | 2005 | 298 | 0.010 |
Why?
|
Species Specificity | 1 | 1988 | 2478 | 0.010 |
Why?
|
Administration, Oral | 1 | 2011 | 3914 | 0.010 |
Why?
|
Genetic Linkage | 2 | 1980 | 2421 | 0.010 |
Why?
|
Prognosis | 1 | 2023 | 29060 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2011 | 4777 | 0.010 |
Why?
|
Regional Blood Flow | 2 | 2001 | 1525 | 0.010 |
Why?
|
Ruthenium | 1 | 2002 | 22 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1989 | 1504 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2530 | 0.010 |
Why?
|
Pedigree | 3 | 1980 | 4642 | 0.010 |
Why?
|
Ribonuclease H | 1 | 2002 | 45 | 0.010 |
Why?
|
Research Design | 1 | 1998 | 5984 | 0.010 |
Why?
|
Regression Analysis | 1 | 1992 | 6459 | 0.010 |
Why?
|
Fluorometry | 1 | 2001 | 106 | 0.010 |
Why?
|
Chemical Precipitation | 1 | 2001 | 179 | 0.010 |
Why?
|
Cytokine Receptor gp130 | 1 | 2001 | 66 | 0.010 |
Why?
|
Centrifugation | 1 | 2001 | 122 | 0.010 |
Why?
|
Receptors, Fibronectin | 1 | 2001 | 39 | 0.010 |
Why?
|
Anions | 1 | 2001 | 133 | 0.010 |
Why?
|
Corticosterone | 1 | 2002 | 310 | 0.010 |
Why?
|
Mutation | 2 | 2023 | 29786 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 1981 | 181 | 0.010 |
Why?
|
Chondroitin Sulfates | 1 | 2001 | 187 | 0.010 |
Why?
|
7-Alkoxycoumarin O-Dealkylase | 1 | 2000 | 2 | 0.010 |
Why?
|
Dicumarol | 1 | 2000 | 6 | 0.010 |
Why?
|
Phenolsulfonphthalein | 1 | 2000 | 3 | 0.010 |
Why?
|
Ileum | 2 | 1994 | 565 | 0.010 |
Why?
|
Cytochrome P-450 CYP2B1 | 1 | 2000 | 21 | 0.010 |
Why?
|
Osteoarthritis | 1 | 1988 | 1036 | 0.010 |
Why?
|
Myeloma Proteins | 1 | 1980 | 72 | 0.010 |
Why?
|
Complement C5a | 1 | 2000 | 107 | 0.010 |
Why?
|
Coumarins | 1 | 2000 | 119 | 0.010 |
Why?
|
Computers | 1 | 2003 | 612 | 0.010 |
Why?
|
Glucuronosyltransferase | 1 | 2000 | 128 | 0.010 |
Why?
|
Aprotinin | 1 | 2000 | 88 | 0.010 |
Why?
|
Membranes, Artificial | 1 | 2002 | 378 | 0.010 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2000 | 141 | 0.010 |
Why?
|
Diazepam | 1 | 2000 | 205 | 0.010 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2000 | 149 | 0.010 |
Why?
|
Threonine | 1 | 1980 | 279 | 0.010 |
Why?
|
Major Histocompatibility Complex | 1 | 2002 | 936 | 0.010 |
Why?
|
Aortic Valve | 1 | 1989 | 1924 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4185 | 0.010 |
Why?
|
Oxazines | 1 | 2000 | 298 | 0.010 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2000 | 179 | 0.010 |
Why?
|
Globins | 1 | 1999 | 416 | 0.010 |
Why?
|
Vasodilation | 1 | 2003 | 944 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1992 | 1572 | 0.010 |
Why?
|
Capillaries | 1 | 2001 | 773 | 0.010 |
Why?
|
Heart Rate | 1 | 2009 | 4092 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 2050 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2000 | 424 | 0.010 |
Why?
|
Karyotyping | 1 | 1980 | 1243 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 1999 | 251 | 0.010 |
Why?
|
Biophysical Phenomena | 1 | 1998 | 327 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2000 | 563 | 0.010 |
Why?
|
Dipeptides | 1 | 1980 | 409 | 0.010 |
Why?
|
Membrane Lipids | 1 | 1998 | 249 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2001 | 1014 | 0.010 |
Why?
|
Chimera | 1 | 1979 | 485 | 0.010 |
Why?
|
Biophysics | 1 | 1998 | 383 | 0.010 |
Why?
|
Peroxidase | 1 | 2000 | 611 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9857 | 0.010 |
Why?
|
Epithelium | 2 | 1993 | 1679 | 0.010 |
Why?
|
Robotics | 1 | 2004 | 899 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2000 | 791 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1996 | 427 | 0.010 |
Why?
|
Keratins | 1 | 1997 | 515 | 0.010 |
Why?
|
Pressure | 1 | 1999 | 1203 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1997 | 688 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2001 | 985 | 0.010 |
Why?
|
Iodine Radioisotopes | 2 | 1989 | 1032 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2010 | 5172 | 0.010 |
Why?
|
Cross Reactions | 1 | 1977 | 841 | 0.010 |
Why?
|
Genes | 1 | 1979 | 1893 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2004 | 2073 | 0.010 |
Why?
|
Epithelial Cells | 2 | 1997 | 3690 | 0.010 |
Why?
|
Immunity | 1 | 1981 | 1014 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 213390 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2000 | 1335 | 0.010 |
Why?
|
Melanocytes | 1 | 1997 | 515 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2009 | 4245 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2001 | 1821 | 0.010 |
Why?
|
Cephradine | 1 | 1993 | 4 | 0.010 |
Why?
|
Penicillin V | 1 | 1993 | 18 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2001 | 15078 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1997 | 1101 | 0.010 |
Why?
|
Diet | 1 | 2011 | 7937 | 0.010 |
Why?
|
Kidney | 2 | 2002 | 7184 | 0.010 |
Why?
|
Body Water | 1 | 1993 | 343 | 0.010 |
Why?
|
Pentetic Acid | 1 | 1992 | 213 | 0.010 |
Why?
|
Gene Products, env | 1 | 1993 | 263 | 0.010 |
Why?
|
Monocytes | 1 | 2001 | 2596 | 0.010 |
Why?
|
Gastrointestinal Motility | 1 | 1992 | 225 | 0.010 |
Why?
|
Thymidine | 1 | 1990 | 310 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1991 | 562 | 0.010 |
Why?
|
Tritium | 1 | 1990 | 745 | 0.010 |
Why?
|
Uridine | 1 | 1990 | 146 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2000 | 3799 | 0.010 |
Why?
|
Heart | 1 | 2002 | 4464 | 0.010 |
Why?
|
Leucine | 1 | 1990 | 560 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2000 | 25628 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1992 | 1799 | 0.010 |
Why?
|
Software | 1 | 2002 | 4441 | 0.000 |
Why?
|
Renal Circulation | 1 | 1988 | 334 | 0.000 |
Why?
|
Horses | 1 | 1988 | 304 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 2001 | 4666 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1992 | 2505 | 0.000 |
Why?
|
Immune Sera | 2 | 1978 | 641 | 0.000 |
Why?
|
Synovial Fluid | 1 | 1988 | 394 | 0.000 |
Why?
|
Cardiac Output | 1 | 1988 | 854 | 0.000 |
Why?
|
Adrenal Glands | 1 | 1988 | 546 | 0.000 |
Why?
|
Fertilization in Vitro | 1 | 1993 | 1284 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 35425 | 0.000 |
Why?
|
Testis | 1 | 1988 | 804 | 0.000 |
Why?
|
Glomerular Filtration Rate | 1 | 1992 | 2166 | 0.000 |
Why?
|
Aged | 2 | 2014 | 163288 | 0.000 |
Why?
|
United States | 1 | 1992 | 69872 | 0.000 |
Why?
|
Aorta, Thoracic | 1 | 1989 | 1084 | 0.000 |
Why?
|
Multiple Myeloma | 1 | 1980 | 5181 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1987 | 1276 | 0.000 |
Why?
|
Chromatography, Agarose | 1 | 1976 | 28 | 0.000 |
Why?
|
Prospective Studies | 1 | 1994 | 53290 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1992 | 57776 | 0.000 |
Why?
|
Genotype | 1 | 1976 | 12952 | 0.000 |
Why?
|